Physician profile
Dave Steven Eichman
NPI 1134373962
$11,868.90
in general payments reported to CMS, 2019-2025
34 companies · $3,437 in 2025
The $3,437 reported for 2025 was more than what 90% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,608 · 2020: $356 · 2021: $771 · 2022: $685 · 2023: $1,059 · 2024: $953 · 2025: $3,437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,104 · Travel and Lodging: $2,303 · Education: $42.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,104.47 |
| Travel and Lodging | $2,302.59 |
| Education | $42.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,980.05 | 2019-2025 | General - Therapies, Wavewriter Alpha Prime 16, Intracept |
| Nevro Corp. | $3,266.81 | 2019-2024 | Senza |
| Vertos Medical, INC. | $1,633.53 | 2019-2021 | |
| Medtronic, INC. | $314.49 | 2021-2024 | Synchromedii, Intellis Adaptivestim |
| Saluda Medical Americas, INC. | $270.82 | 2023-2025 | Evoke Scs, Evoke |
| Globus Medical, INC. | $179.40 | 2025 | Senza |
| Stimwave Technologies Incorporated | $133.24 | 2019-2022 | |
| Nalu Medical, INC. | $102.96 | 2022-2025 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.57 | 2020-2023 | Relistor |
| Medtronic USA, INC. | $86.41 | 2019-2020 | |
| Allergan, INC. | $75.90 | 2019-2021 | |
| Pfizer INC. | $74.60 | 2020-2021 | |
| Spr Therapeutics, INC | $74.04 | 2021-2023 | Sprint Pns System |
| Amgen INC. | $58.32 | 2019-2020 | |
| Abbvie INC. | $55.06 | 2021-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $53.63 | 2025 | |
| Bioventus LLC | $43.27 | 2019-2024 | Bonescalpel & Sonicone (O.R.) |
| Curonix LLC | $42.18 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $41.90 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $35.89 | 2019-2020 | |
| Tersera Therapeutics LLC | $33.26 | 2021 | |
| Pacira Therapeutics, INC. | $27.26 | 2019 | |
| Abbott Laboratories | $24.59 | 2019 | |
| Azurity Pharmaceuticals, INC. | $18.63 | 2023 | Horizant |
| Virtus Pharmaceuticals LLC | $18.41 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.95 | 2025 | |
| Forte Bio-Pharma LLC | $14.62 | 2019 | |
| Integra Lifesciences Corporation | $14.20 | 2023 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Arbor Pharmaceuticals, INC. | $14.07 | 2021 | |
| Baudax Bio INC. | $13.91 | 2020 | |
| Almatica Pharma LLC | $13.49 | 2021 | |
| Scilex Pharmaceuticals INC. | $12.62 | 2019 | |
| Biodelivery Sciences International, INC. | $12.50 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dave Eichman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.